AviadoBio

AviadoBio is developing gene therapies for neurodegenerative diseases including frontotemporal dementia and amyotrophic lateral sclerosis.

Closeup of blue eye on black background

Biotech

AviadoBio secures option to rare eye disease gene therapy

England's AviadoBio is looking to China as a potential source of additional gene therapies.

James Waldron Oct 9, 2025 8:50am

Graphic of two hands shaking under a red and purple light

Astellas pays $50M for option on AviadoBio dementia gene therapy

Oct 8, 2024 7:40am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am

CL chutes

2 Astellas execs to retire—Chutes & Ladders

Aug 5, 2022 9:46am

Gene therapy

AviadoBio gains orphan tag for one-dose dementia gene therapy

Apr 27, 2022 9:18am